Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
FOLFIRI
.
Show all posts
Showing posts with label
FOLFIRI
.
Show all posts
Monday, May 18, 2015
EMA extends approval of Vectibix plus FOLFIRI as first-line treatment for wild-type RAS mCRC
›
Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
›
Home
View web version
